ABCG2 p.Arg383Gly
[switch to full view]Comments [show]
None has been submitted yet.
No.
Sentence
Comment
3
The R383G mutant when transfected into HEK cells was not detectable on immunoblot or by functional assay, while the R383A mutant exhibited detectable but significantly decreased levels compared to wild-type, partial retention in the ER and altered glycosylation.
X
ABCG2 p.Arg383Gly 19406100:3:4
status: VERIFIED41 Mutagenesis and transfection The R383A, R383G, R383H, R383K, and R383G/S384R mutants were generated by site-directed mutagenesis in the pcDNA3.1/Myc-HisA(-) vector (Invitrogen) as previously described [26].
X
ABCG2 p.Arg383Gly 19406100:41:40
status: VERIFIEDX
ABCG2 p.Arg383Gly 19406100:41:65
status: VERIFIED80 Generation of Sf9 cells expressing the R383A and R383G mutants Generation of transfer vectors containing wild-type ABCG2 has been described previously [30,31].
X
ABCG2 p.Arg383Gly 19406100:80:49
status: VERIFIED81 The transfer vectors carrying the R383A and R383G mutants were generated by cloning the SacI fragment of pcDNA 3.1/R383A or R383G into the corresponding site of the pAcUW21-L vector.
X
ABCG2 p.Arg383Gly 19406100:81:44
status: VERIFIEDX
ABCG2 p.Arg383Gly 19406100:81:124
status: VERIFIED93 ATP hydrolysis Sf9 membranes containing wild-type ABCG2, R383A, or R383G were harvested, and membranes were isolated and stored at -80 °C according to the method of Sarkadi et al. [33].
X
ABCG2 p.Arg383Gly 19406100:93:67
status: VERIFIED100 To begin investigating the role of arginine 383 in ABCG2, HEK 293 cells were stably transfected with pcDNA3.1 vectors carrying the R383G and R383A mutants.
X
ABCG2 p.Arg383Gly 19406100:100:131
status: VERIFIED106 To test the functionality of the R383A and R383G mutants, flow cytometry was performed after incubating cells with the ABCG2-substrates mitoxantrone and pheophorbide a, with or without the ABCG2-inhibitor FTC (Fig. 2B).
X
ABCG2 p.Arg383Gly 19406100:106:43
status: VERIFIED110 The R383G mutant, as expected from its absence at the cell surface, did not display transport activity for either mitoxantrone or pheophorbide a.
X
ABCG2 p.Arg383Gly 19406100:110:4
status: VERIFIED113 The R383G mutant clones were virtually not detectable, only clone #22 displayed some level of expression and was also represented by a double band (Fig. 2C).
X
ABCG2 p.Arg383Gly 19406100:113:4
status: VERIFIED118 Finally, Northern blotting was carried out to confirm that the reduced expression of these mutants was not due to poor transfection efficacy; significant amounts of ABCG2 RNA were noted in representative clones of the R383A and R383G mutants (Fig. 2E).
X
ABCG2 p.Arg383Gly 19406100:118:228
status: VERIFIED137 Surface expression, function, protein and RNA levels of the R383A and R383G mutants transfected into HEK 293 cells.
X
ABCG2 p.Arg383Gly 19406100:137:70
status: VERIFIED174 Treatment with mitoxantrone resulted in a similar increase in the amount of the R383G mutant detected on the cell surface (data not shown).
X
ABCG2 p.Arg383Gly 19406100:174:80
status: VERIFIED175 To further analyze the localization of the R383A and R383G mutants in the mammalian cells, immunofluorescent staining followed by confocal microscopy was performed.
X
ABCG2 p.Arg383Gly 19406100:175:53
status: VERIFIED177 The expression level for the R383G mutant was too low to determine localization using confocal microscopy.
X
ABCG2 p.Arg383Gly 19406100:177:29
status: VERIFIED178 Next, we evaluated the R383G and R383A mutations in a heterologous system, using Sf9 insect cells, a transfection system that generally yields high protein levels allowing the study of proteins with low expression levels in mammalian cells [40].
X
ABCG2 p.Arg383Gly 19406100:178:23
status: VERIFIED180 Flow cytometry with the 5D3 monoclonal anti-ABCG2 antibody revealed that, similar to the mammalian cells, the R383A mutant was detectable on the surface in the insect cells, while the R383G mutant was not (Fig. 6B).
X
ABCG2 p.Arg383Gly 19406100:180:184
status: VERIFIED183 We postulated that this arginine might function as an anchor of the first transmembrane alpha helix, thus more conservative substitutions were performed: mutation to the positively charged lysine and introduction of arginine at position 384 instead of 383, creating the R383K and R383G/S384R mutants, followed by stable transfections in HEK 293 cells.
X
ABCG2 p.Arg383Gly 19406100:183:280
status: VERIFIED195 On the other hand, none of the R383G/S384R mutant clones was detectable either on the cell surface by flow cytometry with the 5D3 antibody or on immunoblot with the BXP-21 antibody (data not shown).
X
ABCG2 p.Arg383Gly 19406100:195:31
status: VERIFIED206 In this system mutating arginine 383 to glycine, alanine, histidine or lysine resulted in markedly reduced to no protein expression, impaired glycosylation and retention in the ER.
X
ABCG2 p.Arg383Gly 19406100:206:24
status: VERIFIED253 When arginine 383 was replaced by glycine, a small, neutral amino acid, the mutated protein was no longer expressed on the cell surface.
X
ABCG2 p.Arg383Gly 19406100:253:5
status: VERIFIED